
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Analysis of [ADAP] Adaptimmune Therapeutics plc
Data updated 2025-Apr-15 (Tuesday)Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab
Share
2025-Apr-15 Tuesday
Open | $0.24 | High | $0.25 +4.54% |
---|---|---|---|
Close | $0.25 | Low | $0.23 -4.08% |
Volume | 993 Thousand 0.50x | Volatility | 8.99% |
Change |
+$0.02
+6.67%
|
Streak | ↑ 3 days +16.05% |
20d SMA | $0.26 -3.5% | 50d SMA | $0.42 -41.2% | 100d SMA | $0.52 -52.3% | 200d SMA | $0.77 -67.6% |
RSI | 40 | MACD | 0.01 | ADX | 33.3 | Stochastic Oscillator | 29.7 24.0 |
CCI | -34.0 | ATR | 0.04 | OBV | 126 Million | Chaikin A/D | -125 Million |
Market Cap | 341 M | PEG Ratio | Trailing P/E | Forward P/E | |||
Price/Sales (ttm) | 4.6 | Price/Book (mrq) | 8.62 | EV/Revenue (ttm) | 3.63 | EV/EBITDA (ttm) | -1.71 |
% Held by Insiders | 0.21% | % Held by Institutions | 70.02% | Shares Short | 3.11 M | Shares Short (prior month) | 2.93 M |
Short Ratio | 1.55 | Short % of Outstanding | 1.26% | Short % of Float | 0.47% | Shares Short Change (mom) | +6.1% |
Revenue/Share (ttm) | $0.30 | Profit Margin (ttm) | -188.90% | Operating Margin (ttm) | EBITDA (ttm) | -128 M | |
Diluted EPS (ttm) | $-0.54 | Current Ratio (mrq) | 2.85 | Return on Assets (ttm) | -28.22% | Return on Equity (ttm) | -187.61% |
Qtr Earnings Growth (yoy) | Qtr Revenue Growth (yoy) | -97.90% | Operating Cash Flow (ttm) | -141 M | Free Cash Flow (ttm) | -73.8 M | |
Choose view type
Daily Performance for Adaptimmune Therapeutics plc. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)
Note: Performance over Key Timeperiods for Adaptimmune Therapeutics plc up to close of 2025-Apr-15 at $0.25
Period | Frequency | Performance | % off High | % off Low | Volatility | % off SMA | % off EMA | Relative Volume |
---|---|---|---|---|---|---|---|---|
01 Trailing 5-days
|
|
+10.59%
|
-0.6%
|
+22.6%
|
25.0%
|
+8.1%
|
+4.8%
|
0.50x
|
02 Trailing 10-days
|
|
-0.20%
|
-24.4%
|
+22.6%
|
65.0%
|
-1.1%
|
+1.5%
|
0.66x
|
03 Trailing 20-days
|
|
-45.18%
|
-46.9%
|
+27.9%
|
135.0%
|
-3.5%
|
-11.3%
|
1.68x
|
04 Trailing 30-days
|
|
-48.45%
|
-52.3%
|
+27.9%
|
160.0%
|
-23.8%
|
-22.3%
|
1.32x
|
05 Trailing 50-days
|
|
-57.57%
|
-59.8%
|
+27.9%
|
210.0%
|
-41.2%
|
-35.7%
|
0.97x
|
06 Trailing 100-days
|
|
-58.07%
|
-66.3%
|
+27.9%
|
270.0%
|
-52.3%
|
-51.4%
|
1.07x
|
07 Trailing 200-days
|
|
-74.56%
|
-83.1%
|
+27.9%
|
640.0%
|
-67.6%
|
-63.1%
|
1.03x
|
08 Month-to-date
|
|
+26.65%
|
-24.4%
|
+27.9%
|
65.0%
|
|
|
|
09 Quarter-to-date
|
|
+26.65%
|
-24.4%
|
+27.9%
|
65.0%
|
|
|
|
10 Year-to-date
|
|
-53.68%
|
-63.6%
|
+27.9%
|
245.0%
|
|
|
|
11 Trailing 52-weeks
|
|
-76.24%
|
-83.1%
|
+27.9%
|
640.0%
|
|
|
|
2-week Performance Benchmarks for Adaptimmune Therapeutics plc:
Related to Adaptimmune Therapeutics plc
Information for Adaptimmune Therapeutics plc
Current Detail : Recent daily/monthly performance & benchmark comparison Currently Viewing
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-Apr-15 on Google
SEC Reports : Quarterly reports around 2025-Apr-15 on SEC Edgar
Compare Adaptimmune Therapeutics plc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Adaptimmune Therapeutics plc
Industry : Biotechnology industry performance which includes Adaptimmune Therapeutics plc